Morgan Stanley Bullish on Axsome Therapeutics
Morgan Stanley, one of the world's leading financial institutions, has recently assumed coverage of Axsome Therapeutics (AXSM) and given it an "overweight" rating. This comes as no surprise to many in the investment world, as Axsome has been making waves with its innovative treatments for neurological disorders. Axsome Therapeutics specializes in developing therapies for central nervous system (CNS) disorders, with a focus on depression and migraines.
Jim Cramer Gives Thumbs Up to Joby Aviation
If you're a retail investor looking for potential opportunities in the aviation industry, then you'll want to pay attention to what Jim Cramer has to say. The renowned financial expert recently discussed Joby Aviation, a company that specializes in electric vertical takeoff and landing (eVTOL) aircraft. And his verdict? He's not going to fight against it. So what does this mean for investors?
12 Hidden Gems for Savvy Investors
Small cap stocks may not always get the attention of their larger counterparts, but they often offer significant upside potential for savvy investors. These are companies with a market capitalization of $300 million to $2 billion, making them relatively unknown and undervalued by the market. However, with thorough research and a keen eye, these small cap stocks can be great investments with high growth opportunities.
Evotec Joins Consortium to Revolutionize Kidney Injury Drug Discovery
Evotec (EVO) has recently joined the NURTuRE-AKI Consortium, a global collaboration of leading research institutions and pharmaceutical companies, in an effort to advance drug discovery for acute kidney injury (AKI). This move marks a significant step in the fight against kidney disease, which affects millions of people worldwide and has a high mortality rate. AKI is a common complication in hospitalized patients and can lead to severe kidney damage or failure if left untreated.
Innovative Industrial Properties
With the current economic climate, it can be challenging for investors to find stable and profitable opportunities. However, one company, Innovative Industrial Properties (IIP), has been able to navigate the market's headwinds and leverage its strengths to continue producing strong returns for its shareholders. IIP is a real estate investment trust (REIT) that specializes in the acquisition and management of industrial properties used for the cultivation and processing of medical-use cannabis.
Jim Cramer Calls Danaher Corporation “Fool’s Gold”
Jim Cramer, host of CNBC's Mad Money, recently expressed his disappointment with Danaher Corporation (DHR), calling it "fool's gold." The company, which specializes in medical and industrial products, has been on a downward trend in the stock market despite strong financials. Cramer believes that Danaher's stock price is artificially inflated due to its recent spinoff of its dental division, Envista Holdings.